Condition
Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified clinical trials and research
As of November 12, 2026, Find a Trial lists 3 Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified clinical trials that are recruiting, in United States. By phase: Phase 1 (2), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 1Country
Newest Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Belinostat combined with azacitidine or pralatrexate for relapsed or refractory TFH/Nodal PTCL and related T-cell lymphomas | Phase 1 | Duarte, California and 1 other locations | Recruiting | Jul 9, 2026 |
| Vaccine treatment for relapsed or refractory blood cancers | Phase 1 | Scottsdale, Arizona and 1 other locations | Recruiting | Jan 11, 2017 |
| Durvalumab With or Without Lenalidomide for Relapsed/Refractory Cutaneous or Peripheral T-Cell Lymphoma | Phase 1/2 | Duarte, California and 3 other locations | Recruiting | Jan 5, 2017 |
All recruiting trials (3)
-
Belinostat combined with azacitidine or pralatrexate for relapsed or refractory TFH/Nodal PTCL and related T-cell lymphomas
This early-phase trial tests whether adding belinostat to azacitidine or pralatrexate is safe and may help treat adults with relapsed or refractory follicular helper T-cell lymphoma and related T-cell cancers.
-
Vaccine treatment for relapsed or refractory blood cancers
This study is testing a new vaccine treatment for people with relapsed or hard-to-treat blood cancers to see if it can help them feel better and live longer.
-
Durvalumab With or Without Lenalidomide for Relapsed/Refractory Cutaneous or Peripheral T-Cell Lymphoma
This study tests whether adding lenalidomide to durvalumab is safe and helps treating relapsed or refractory cutaneous or peripheral T-cell lymphoma.
Related topics
Quick answers
How many Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.